JP2022523188A5 - - Google Patents
Info
- Publication number
- JP2022523188A5 JP2022523188A5 JP2021548675A JP2021548675A JP2022523188A5 JP 2022523188 A5 JP2022523188 A5 JP 2022523188A5 JP 2021548675 A JP2021548675 A JP 2021548675A JP 2021548675 A JP2021548675 A JP 2021548675A JP 2022523188 A5 JP2022523188 A5 JP 2022523188A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024173444A JP2025016471A (ja) | 2019-02-22 | 2024-10-02 | Ｃｄ３３抗体とそれを用いた癌を治療する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962809091P | 2019-02-22 | 2019-02-22 | |
| US62/809,091 | 2019-02-22 | ||
| PCT/US2020/019351 WO2020172621A1 (en) | 2019-02-22 | 2020-02-21 | Cd33 antibodies and methods of using the same to treat cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024173444A Division JP2025016471A (ja) | 2019-02-22 | 2024-10-02 | Ｃｄ３３抗体とそれを用いた癌を治療する方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022523188A JP2022523188A (ja) | 2022-04-21 |
| JP2022523188A5 true JP2022523188A5 (https=) | 2023-03-06 |
| JPWO2020172621A5 JPWO2020172621A5 (https=) | 2023-03-06 |
| JP7598324B2 JP7598324B2 (ja) | 2024-12-11 |
Family
ID=72144738
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021548675A Active JP7598324B2 (ja) | 2019-02-22 | 2020-02-21 | Ｃｄ３３抗体とそれを用いた癌を治療する方法 |
| JP2024173444A Pending JP2025016471A (ja) | 2019-02-22 | 2024-10-02 | Ｃｄ３３抗体とそれを用いた癌を治療する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024173444A Pending JP2025016471A (ja) | 2019-02-22 | 2024-10-02 | Ｃｄ３３抗体とそれを用いた癌を治療する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12441793B2 (https=) |
| EP (1) | EP3927749A4 (https=) |
| JP (2) | JP7598324B2 (https=) |
| KR (1) | KR20210142628A (https=) |
| CN (2) | CN120329441A (https=) |
| AU (1) | AU2020225631A1 (https=) |
| BR (1) | BR112021016398A2 (https=) |
| CA (1) | CA3131019A1 (https=) |
| CO (1) | CO2021011944A2 (https=) |
| MX (1) | MX2021009975A (https=) |
| WO (1) | WO2020172621A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018308088B2 (en) | 2017-07-25 | 2025-05-29 | Truebinding, Inc. | Treating cancer by blocking the interaction of TIM-3 and its ligand |
| EP3636752A4 (en) | 2018-07-25 | 2021-04-28 | Alteogen, Inc. | NEW HYALURONIC ACID HYDROLYZING ENZYMUTANTS AND THE PHARMACEUTICAL COMPOSITION CONTAINING THIS |
| AU2020214796A1 (en) | 2019-01-30 | 2021-07-29 | Truebinding, Inc. | Anti-Gal3 antibodies and uses thereof |
| MY204342A (en) | 2019-03-25 | 2024-08-24 | Alteogen Inc | Pharmaceutical composition, comprising human hyaluronidase ph20 variant and drug, for subcutaneous injection |
| WO2021083467A1 (en) * | 2019-10-28 | 2021-05-06 | Y-Mabs Therapeutics, Inc. | Administration of cd22, cd33 and/or tim-3 antibodies using ommaya reservoirs for the treatment of cns cancer or neurodegenerative diseases |
| WO2021242776A2 (en) | 2020-05-26 | 2021-12-02 | Truebinding, Inc. | Methods of treating inflammatory diseases by blocking galectin-3 |
| WO2021242848A1 (en) * | 2020-05-27 | 2021-12-02 | Memorial Sloan Kettering Cancer Center | Anti-gd2 sada conjugates and uses thereof |
| JP7622088B2 (ja) | 2020-08-07 | 2025-01-27 | アルテオジェン・インコーポレイテッド | 組換えヒアルロニダーゼの生産方法 |
| US20240415888A1 (en) * | 2021-10-20 | 2024-12-19 | Memorial Sloan Kettering Cancer Center | Anti-tshr multi-specific antibodies and uses thereof |
| EP4608871A1 (en) * | 2022-10-26 | 2025-09-03 | Memorial Sloan-Kettering Cancer Center | Cd33 antibody compositions for treating alzheimer's disease |
| AU2024283114A1 (en) * | 2023-06-01 | 2026-01-22 | Actinium Pharmaceuticals, Inc. | Combination therapies for the treatment of cd33-positive hematological malignancies harboring mutations |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101210048A (zh) * | 2006-12-29 | 2008-07-02 | 中国医学科学院血液学研究所 | 用于靶向结合髓系白血病细胞的抗cd33的工程抗体及其表达载体和用途 |
| US20130309223A1 (en) | 2012-05-18 | 2013-11-21 | Seattle Genetics, Inc. | CD33 Antibodies And Use Of Same To Treat Cancer |
| US10519248B2 (en) * | 2014-07-25 | 2019-12-31 | Memorial Sloan Kettering Cancer Center | Bispecific HER2 and CD3 binding molecules |
| JP7376977B2 (ja) | 2015-06-12 | 2023-11-09 | アレクトル エルエルシー | 抗ｃｄ３３抗体及びその使用方法 |
| DK3380522T5 (da) | 2015-11-25 | 2024-09-30 | Visterra Inc | Antistofmolekyler til april og anvendelser deraf |
| WO2017172981A2 (en) | 2016-03-29 | 2017-10-05 | University Of Southern California | Chimeric antigen receptors targeting cancer |
| CN110352068A (zh) * | 2016-12-02 | 2019-10-18 | 南加利福尼亚大学 | 合成的免疫受体及其使用方法 |
| KR20190140943A (ko) | 2017-04-24 | 2019-12-20 | 메모리얼 슬로안 케터링 캔서 센터 | 항-cd33 항체 제제 |
| KR102733407B1 (ko) | 2017-08-03 | 2024-11-21 | 알렉터 엘엘씨 | 항-cd33 항체 및 이의 이용 방법 |
| JOP20190116A1 (ar) | 2018-05-24 | 2019-11-24 | Janssen Biotech Inc | الأجسام المضادة لتكتل التمايز 33 (cd33)، والأجسام المضادة ثنائية النوعية لتكتل التمايز 33 (cd33)/تكتل التمايز 3 (cd3) واستخداماتها |
-
2020
- 2020-02-21 AU AU2020225631A patent/AU2020225631A1/en active Pending
- 2020-02-21 KR KR1020217029876A patent/KR20210142628A/ko active Pending
- 2020-02-21 US US17/432,265 patent/US12441793B2/en active Active
- 2020-02-21 JP JP2021548675A patent/JP7598324B2/ja active Active
- 2020-02-21 EP EP20758925.0A patent/EP3927749A4/en active Pending
- 2020-02-21 BR BR112021016398A patent/BR112021016398A2/pt unknown
- 2020-02-21 CN CN202411916396.4A patent/CN120329441A/zh active Pending
- 2020-02-21 MX MX2021009975A patent/MX2021009975A/es unknown
- 2020-02-21 CA CA3131019A patent/CA3131019A1/en active Pending
- 2020-02-21 WO PCT/US2020/019351 patent/WO2020172621A1/en not_active Ceased
- 2020-02-21 CN CN202080029923.3A patent/CN114502584B/zh active Active
-
2021
- 2021-09-13 CO CONC2021/0011944A patent/CO2021011944A2/es unknown
-
2024
- 2024-10-02 JP JP2024173444A patent/JP2025016471A/ja active Pending